当前位置:首页 - 行情中心 - 迪哲医药-U(688192) - 财务分析 - 现金流量表

迪哲医药-U

(688192)

  

流通市值:262.02亿  总市值:264.84亿
流通股本:4.60亿   总股本:4.65亿

现金流量表

报告期2025-09-302025-06-302025-03-312024-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金559,618,110.76346,296,077.75164,190,860.93436,632,069.94
  收到其他与经营活动有关的现金35,498,609.2535,726,130.6725,289,636.2448,468,571.51
  经营活动现金流入小计595,116,720.01382,022,208.42189,480,497.17485,100,641.45
  购买商品、接受劳务支付的现金365,715,963.02216,360,655.34112,191,453440,106,399.09
  支付给职工以及为职工支付的现金434,636,966.7288,977,995.47158,493,226.49478,161,922.79
  支付的各项税费13,533,240.174,727,195.752,481,587.6620,704,986.42
  支付其他与经营活动有关的现金205,287,398.1136,625,730.647,981,189.48196,652,797.42
  经营活动现金流出小计1,019,173,567.99646,691,577.16321,147,456.631,135,626,105.72
  经营活动产生的现金流量净额-424,056,847.98-264,669,368.74-131,666,959.46-650,525,464.27
二、投资活动产生的现金流量:
  收回投资收到的现金7,282,902,008.733,631,596,974.15732,182,713.484,018,911,576.93
  处置固定资产、无形资产和其他长期资产收回的现金净额8,032.957,607.2--
  投资活动现金流入小计7,282,910,041.683,631,604,581.35732,182,713.484,018,911,576.93
  购建固定资产、无形资产和其他长期资产支付的现金149,943,303.92112,832,364.7675,832,800.06137,575,882.85
  投资支付的现金7,585,000,0004,036,000,000785,000,0003,919,410,000
  投资活动现金流出小计7,734,943,303.924,148,832,364.76860,832,800.064,056,985,882.85
  投资活动产生的现金流量净额-452,033,262.24-517,227,783.41-128,650,086.58-38,074,305.92
三、筹资活动产生的现金流量:
  吸收投资收到的现金1,776,367,935.511,776,367,935.51-100,000,000
  取得借款收到的现金557,217,810.54557,217,810.54391,343,495.54963,356,991.23
  收到其他与筹资活动有关的现金---58,266,328.26
  筹资活动现金流入小计2,333,585,746.052,333,585,746.05391,343,495.541,121,623,319.49
  偿还债务支付的现金639,753,685.12524,177,885.12112,665,800203,726,151.95
  分配股利、利润或偿付利息支付的现金25,979,444.0918,961,195.249,055,170.7720,553,670.36
  支付其他与筹资活动有关的现金26,944,199.2414,071,001.347,005,473.730,330,708.04
  筹资活动现金流出小计692,677,328.45557,210,081.7128,726,444.47254,610,530.35
  筹资活动产生的现金流量净额1,640,908,417.61,776,375,664.35262,617,051.07867,012,789.14
四、汇率变动对现金及现金等价物的影响-223,484.38-77,388.6341,823.67-2,449,850.28
五、现金及现金等价物净增加额764,594,823994,401,123.572,341,828.7175,963,168.67
  加:期初现金及现金等价物余额249,889,742.63249,889,742.63249,889,742.6373,926,573.96
  期末现金及现金等价物余额1,014,484,565.631,244,290,866.2252,231,571.33249,889,742.63
补充资料:
  净利润--379,042,400.14--939,655,188.7
  固定资产和投资性房地产折旧-3,996,203.15-8,069,923.78
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-3,996,203.15-8,069,923.78
  无形资产摊销-16,792,781.84-33,663,118.86
  长期待摊费用摊销-4,111,508.65-10,653,489.06
  递延收益摊销--717,522.73--
  处置固定资产、无形资产和其他长期资产的损失--279.52--
  公允价值变动损失--11,219,000.56--14,450,692.6
  财务费用-17,229,479.65-25,204,374.51
  存货的减少-3,567,558.94--20,644,075.82
  经营性应收项目的减少--16,212,458.58-23,699,487.15
  经营性应付项目的增加-49,664,403.84-65,601,150.2
  其他-34,316,897.32-132,818,342.27
  现金的期末余额-1,244,290,866.2-249,889,742.63
  减:现金的期初余额-249,889,742.63-73,926,573.96
  现金及现金等价物的净增加额-994,401,123.57-175,963,168.67
公告日期2025-10-312025-08-232025-04-302025-04-30
审计意见(境内)标准无保留意见
TOP↑